Merrimack Pharmaceuticals
MACK
#8368
Rank
A$0.33 B
Marketcap
A$22.80
Share price
0.00%
Change (1 day)
-1.32%
Change (1 year)

EPS for Merrimack Pharmaceuticals (MACK)

EPS in 2024 (TTM): A$21.22

According to Merrimack Pharmaceuticals's latest financial reports the company's current EPS (TTM) is A$20.88. In 2016 the company made an earnings per share (EPS) of A-$18.43 an increase over its 2015 EPS that were of A-$19.89.

EPS history for Merrimack Pharmaceuticals from 2012 to 2024

Annual EPS

Year EPS Change
2024 (TTM)A$21.22
2016A-$18.43-7.35%
2015A-$19.8965%
2014A-$12.05-39.39%
2013A-$19.89-54.01%
2012A-$43.25

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
A$5.58-73.26%๐Ÿ‡ซ๐Ÿ‡ท France
AVEO Oncology
AVEO
A-$1.27-106.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
A-$0.18-100.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Clovis Oncology
CLVS
A-$2.85-113.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
A-$115.59-653.46%๐Ÿ‡บ๐Ÿ‡ธ USA